OSUR OraSure Technologies Expected net earnings per share growth this year
OraSure Technologies (OSUR) is facing margin pressure due to declining demand for COVID tests and fierce competition. The annual EPS change ratio clearly demonstrates these fluctuations, where the 36.60 metric serves as the target level. High pipeline automation minimizes manual labor, while steady sales of sample collection systems support cash flow, offsetting the impact of the post-pandemic slump.
Analytical breakdowns and data insights for company OraSure Technologies, Inc. (OSUR)
- current quotes and average value forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital OraSure Technologies|OSUR - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient OraSure Technologies Inc|OSUR - Company Total Debt|Debts to Book Capitalization OraSure Technologies|OSUR - Company Long-Term Debt|Company Short-Term Loans and Borrowings OraSure|Immediate Liquidity orasure.com
- company profitability and valuation multiples indicators:
OSUR - Net Income|Expected Net Income OraSure Technologies|OSUR - Price to Earnings Ratio|Market Cap to Future Earnings Ratio OraSure Technologies|OSUR - PEG Multiple|Company Value to EBITDA OraSure|OSUR - Operating profit EBITDA|Net earnings per share for the last 12 months OraSure|OSUR - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months orasure.com|OSUR - Earnings per share growth in current year|Projected earnings per share growth rate for next year OraSure Technologies
- revenue and sales proceeds data:
Summary company analysis:OraSure Technologies
OraSure Technologies (OSUR) is currently transforming its business model, shifting from pandemic-era products toward scaling molecular diagnostic systems. The annual earnings per share trajectory reflects EPS dynamics relative to the previous year, allowing for an assessment of this pivot's effectiveness through the lens of net income; meanwhile, sharp fluctuations in the trend line require correlation with debt load to accurately calculate the cost of capital.
Main competitors
Net earnings per share change in current year Agilent Tech A|Earnings per share growth in current year Quest Corp|Illumina, Inc. (ILMN) - Expected net earnings per share growth this year|Earnings growth in current year EXAS|RVTY (Revvity) - Earnings per share increase in current year|Earnings per share growth in current year bio-rad.com BIO|NNNN: Earnings per share growth this year|Sotera Health Corp - Earnings growth in current year|Expected net earnings per share growth this year QuidelOrtho QDEL|OPK (OPKO Health) - Net earnings per share growth this year|Earnings per share growth rate in current year CareDx, Inc. (CDNA)|Net earnings per share growth this year MRVI|Earnings per share growth rate in current year Fulgent FLGT|Earnings per share growth in current year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year XGN (exagen.com)|MDxHealth Inc. - Earnings per share growth in current year|Lucid Diagnostics, Inc - Earnings growth in current year|Expected net earnings per share growth this year Prenetics Global Limited PRE|Insight Molecular (IMDX) - Earnings per share growth in current year|TRIB (Trinity Biotech PLC) - Earnings per share growth in current year|Earnings per share growth in current year ProPhase Labs|Ainos (AIMD) - Expected net earnings per share growth this year|Net earnings per share growth this year CODX (Co-Diagnostics)|HSCS (Heart Test Labs) - Earnings per share increase in current year|Earnings per share growth in current year Biomerica BMRA|CDIO: Earnings per share growth this year|Onconetix Inc - Earnings growth in current year|Expected net earnings per share growth this year Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Earnings per share growth in current year|Vermillion - Earnings per share increase in current year|AXDX (Accelerate Diagnostics Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE, N.V. (CNTG)|Net earnings per share growth this year ENZ (Enzo)|Earnings growth in current year Fresh2 Group Limited (FRES)|Earnings growth in current year GENE (GTG Labs)|ME - Net earnings per share growth this year|Psychemedics Inc - Earnings growth in current year
